Trident Texofab Limited returned to profitability in the first quarter of FY26, reporting a net profit after tax of ₹52.18 lakh for the period ended June 30, 2026. This result marks a sharp reversal from the net loss of ₹200.94 lakh posted in the previous quarter (Q4FY25), signaling an operational improvement despite a decline in revenue. The company’s total income from operations fell to ₹2,632.79 lakh in Q1FY26, compared to ₹3,410.25 lakh in the prior quarter and ₹2,851.58 lakh in the same quarter last year.

The Board of Directors approved the unaudited standalone financial results on August 10, 2026, following a review by the Audit Committee. The results were filed with the stock exchanges pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company disclosed these figures via newspaper advertisements in Financial Express (English and Gujarati editions) on August 12, 2026, in compliance with Regulation 30 and Regulation 47 of the SEBI Listing Regulations.

Financial Performance Highlights

The company generated a pre-tax profit of ₹68.72 lakh in the current quarter, up from a pre-tax loss of ₹130.75 lakh in Q4FY25. Earnings per share stood at ₹0.35 for both basic and diluted calculations, a notable improvement from the negative EPS of ₹-1.30 in the preceding quarter. Equity share capital remained unchanged at ₹1,499.58 lakh.

What the Numbers Show

The divergence between declining revenue and rising profitability suggests cost optimization or margin expansion drove the turnaround. While total income dropped by approximately 23% quarter-on-quarter, the company managed to swing from a significant loss to a profit position. This indicates that fixed costs may have been better absorbed or variable costs reduced relative to sales volume, although specific operational drivers were not detailed in the filing. The year-over-year comparison shows lower profits than Q1FY25 (₹101.59 lakh), highlighting that while the immediate trend is positive, it has not yet returned to the levels seen in the corresponding period of the previous fiscal year.

Trident Texofab reported a net profit of ₹52.18 lakh for the quarter ended June 30, 2026, marking a sharp recovery from the ₹200.94 lakh loss recorded in the same period last year. Revenue from operations declined to ₹2,614.26 lakh from ₹2,807.68 lakh in Q1FY25, yet the company achieved profitability driven by lower material costs and improved operational efficiency. The turnaround is significant for shareholders as it ends a streak of losses in the preceding quarter, demonstrating effective cost management despite a dip in sales volume.

The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors in a meeting held on August 10, 2026. The results were reviewed by the Statutory Auditor, Shah Kailash & Associates LLP (FRN: 109647W), under Standard on Review Engagement (SRE) 2410. The disclosure was made pursuant to Regulation 33 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. An extract of the financial results will be published in newspapers and made available on the company’s website.

Financial Performance

The company’s total income stood at ₹2,632.79 lakh, down from ₹2,851.58 lakh in Q1FY25. Despite the revenue dip, total expenses decreased significantly to ₹2,564.07 lakh from ₹2,714.67 lakh in the prior year quarter. This cost discipline resulted in a profit before tax of ₹68.72 lakh, compared to ₹136.92 lakh in Q1FY25. After accounting for a total tax expense of ₹16.54 lakh, the net profit for the period was ₹52.18 lakh. Earnings per share (basic) were ₹0.35, up from ₹0.72 in the previous year but a stark improvement from the loss of ₹1.30 per share in Q4FY25.

Auditor Resignation and Appointment

Shah Kailash & Associates LLP resigned as Statutory Auditor with effect from August 10, 2026. In their resignation letter, the firm stated that increasing professional commitments and workload made it difficult to devote requisite time and resources to the role. They confirmed there were no disagreements with management regarding accounting policies or auditing procedures. The firm had been appointed at the 16th Annual General Meeting on September 27, 2024, for a four-year term ending in FY28. The resignation was disclosed under Regulation 30 of the SEBI Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Concurrently, the Board appointed M/s. Prit Agrawal & Co. (FRN: 152249W) as the Internal Auditor for the financial year 2026-27. The firm, based in Ahmedabad, provides services including direct and indirect taxation, statutory audit, and business advisory. This appointment was also disclosed pursuant to Regulation 30 of the SEBI Listing Regulations.

What the Numbers Show

The divergence between revenue decline and profit improvement highlights a structural shift in cost management. While revenue from operations fell by approximately 6.9% year-on-year, total expenses dropped by roughly 5.5%. More critically, the cost of materials consumed plummeted from ₹647.39 lakh in Q1FY25 to ₹233.29 lakh in Q1FY26, a reduction of over 64%. This suggests either a change in product mix towards lower-cost items or significant efficiencies in procurement. However, purchases of stock-in-trade rose sharply to ₹2,028.42 lakh from ₹1,798.39 lakh, indicating increased inventory buildup despite lower sales volume. Investors should monitor whether this inventory accumulation aligns with future demand expectations or signals potential working capital pressure.